Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Clinical trial NCT03869190 · TERMINATED
Trial details
- NCT number
- NCT03869190
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2025-10-08
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.